RU2007129264A - Полиморф cci-779 и его применение - Google Patents
Полиморф cci-779 и его применение Download PDFInfo
- Publication number
- RU2007129264A RU2007129264A RU2007129264/04A RU2007129264A RU2007129264A RU 2007129264 A RU2007129264 A RU 2007129264A RU 2007129264/04 A RU2007129264/04 A RU 2007129264/04A RU 2007129264 A RU2007129264 A RU 2007129264A RU 2007129264 A RU2007129264 A RU 2007129264A
- Authority
- RU
- Russia
- Prior art keywords
- ccl
- polymorph
- solid
- tert
- bme
- Prior art date
Links
- CBPNZQVSJQDFBE-FUXHJELOSA-N Temsirolimus Chemical compound C1C[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 CBPNZQVSJQDFBE-FUXHJELOSA-N 0.000 title 1
- 229960000235 temsirolimus Drugs 0.000 title 1
- CBPNZQVSJQDFBE-HXVVJGEPSA-N ccl-779 Chemical compound C1C[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 CBPNZQVSJQDFBE-HXVVJGEPSA-N 0.000 claims 13
- 238000000034 method Methods 0.000 claims 7
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims 6
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims 6
- 239000007787 solid Substances 0.000 claims 6
- 239000000725 suspension Substances 0.000 claims 4
- 239000008259 solid foam Substances 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 238000005406 washing Methods 0.000 claims 2
- 239000011230 binding agent Substances 0.000 claims 1
- 239000002738 chelating agent Substances 0.000 claims 1
- 238000000113 differential scanning calorimetry Methods 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 150000002739 metals Chemical class 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000003002 pH adjusting agent Substances 0.000 claims 1
- 238000001556 precipitation Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 238000002411 thermogravimetry Methods 0.000 claims 1
- 238000001757 thermogravimetry curve Methods 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65137405P | 2005-02-09 | 2005-02-09 | |
| US60/651,374 | 2005-02-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2007129264A true RU2007129264A (ru) | 2009-03-20 |
Family
ID=36570939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2007129264/04A RU2007129264A (ru) | 2005-02-09 | 2006-01-25 | Полиморф cci-779 и его применение |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7442707B2 (enExample) |
| EP (1) | EP1856130A1 (enExample) |
| JP (1) | JP2008530090A (enExample) |
| KR (1) | KR20070107030A (enExample) |
| CN (1) | CN101115759A (enExample) |
| AR (1) | AR052479A1 (enExample) |
| AU (1) | AU2006213061A1 (enExample) |
| BR (1) | BRPI0607932A2 (enExample) |
| CA (1) | CA2595766A1 (enExample) |
| CR (1) | CR9257A (enExample) |
| GT (1) | GT200600044A (enExample) |
| IL (1) | IL184560A0 (enExample) |
| MX (1) | MX2007009590A (enExample) |
| NO (1) | NO20073725L (enExample) |
| PE (1) | PE20060996A1 (enExample) |
| RU (1) | RU2007129264A (enExample) |
| TW (1) | TW200638932A (enExample) |
| WO (1) | WO2006086172A1 (enExample) |
| ZA (1) | ZA200706628B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8551512B2 (en) * | 2004-03-22 | 2013-10-08 | Advanced Cardiovascular Systems, Inc. | Polyethylene glycol/poly(butylene terephthalate) copolymer coated devices including EVEROLIMUS |
| RU2008120670A (ru) * | 2005-12-07 | 2010-01-20 | Вайет (Us) | Масштабируемый способ получения 42-сложного эфира рапамицина из 42-сложного эфира рапамицина бороната |
| RU2008120712A (ru) * | 2005-12-07 | 2010-01-20 | Вайет (Us) | Способы получения кристаллического рапамицина и определения кристалличности соединений рапамицина при помощи дифференциальной сканирующей калориметрии |
| KR20080077618A (ko) * | 2005-12-07 | 2008-08-25 | 와이어쓰 | 정제된 결정체 ｃｃｉ-779 의 제조 방법 |
| TW200824713A (en) * | 2006-10-18 | 2008-06-16 | Wyeth Corp | Processes for the synthesis of individual isomers of mono-PEG CCI-779 |
| CN102282457A (zh) * | 2009-01-21 | 2011-12-14 | 拜康有限公司 | 确定西罗莫司稳定性的方法和制备其稳定形式的工艺 |
| US10682415B2 (en) | 2013-07-22 | 2020-06-16 | Wisconsin Alumni Research Foundation | Thermogel formulation for combination drug delivery |
| CN109020995A (zh) * | 2017-06-12 | 2018-12-18 | 鲁南制药集团股份有限公司 | 一种替西罗莫司的晶型物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5362718A (en) | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
| US6277983B1 (en) * | 2000-09-27 | 2001-08-21 | American Home Products Corporation | Regioselective synthesis of rapamycin derivatives |
| TWI256395B (en) | 1999-09-29 | 2006-06-11 | Wyeth Corp | Regioselective synthesis of rapamycin derivatives |
| CA2455311A1 (en) | 2001-08-22 | 2003-03-06 | Wyeth | Rapamycin dialdehydes |
| EP1419154B1 (en) | 2001-08-22 | 2005-10-05 | Wyeth | Rapamycin 29-enols |
| WO2005010010A1 (en) | 2003-07-16 | 2005-02-03 | Wyeth | Cci-779 isomer c |
| PT1658295E (pt) * | 2003-08-07 | 2007-09-25 | Wyeth Corp | Síntese regiosselectiva de cci-779 |
| AU2004270154A1 (en) * | 2003-09-03 | 2005-03-17 | Wyeth | Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositions containing the same |
| EP1737869A1 (en) * | 2004-04-14 | 2007-01-03 | Wyeth a Corporation of the State of Delaware | Regiospecific synthesis of rapamycin 42-ester derivatives |
-
2006
- 2006-01-25 EP EP06734012A patent/EP1856130A1/en not_active Withdrawn
- 2006-01-25 US US11/339,728 patent/US7442707B2/en not_active Expired - Fee Related
- 2006-01-25 RU RU2007129264/04A patent/RU2007129264A/ru not_active Application Discontinuation
- 2006-01-25 AU AU2006213061A patent/AU2006213061A1/en not_active Abandoned
- 2006-01-25 CA CA002595766A patent/CA2595766A1/en not_active Abandoned
- 2006-01-25 BR BRPI0607932A patent/BRPI0607932A2/pt not_active IP Right Cessation
- 2006-01-25 WO PCT/US2006/003098 patent/WO2006086172A1/en not_active Ceased
- 2006-01-25 CN CNA200680004408XA patent/CN101115759A/zh not_active Withdrawn
- 2006-01-25 KR KR1020077018347A patent/KR20070107030A/ko not_active Withdrawn
- 2006-01-25 JP JP2007555124A patent/JP2008530090A/ja not_active Withdrawn
- 2006-01-25 MX MX2007009590A patent/MX2007009590A/es not_active Application Discontinuation
- 2006-02-03 PE PE2006000136A patent/PE20060996A1/es not_active Application Discontinuation
- 2006-02-06 TW TW095103902A patent/TW200638932A/zh unknown
- 2006-02-07 GT GT200600044A patent/GT200600044A/es unknown
- 2006-02-08 AR ARP060100451A patent/AR052479A1/es unknown
-
2007
- 2007-07-12 IL IL184560A patent/IL184560A0/en unknown
- 2007-07-18 CR CR9257A patent/CR9257A/es not_active Application Discontinuation
- 2007-07-18 NO NO20073725A patent/NO20073725L/no not_active Application Discontinuation
- 2007-08-08 ZA ZA200706628A patent/ZA200706628B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20060178392A1 (en) | 2006-08-10 |
| JP2008530090A (ja) | 2008-08-07 |
| NO20073725L (no) | 2007-09-05 |
| WO2006086172A1 (en) | 2006-08-17 |
| GT200600044A (es) | 2006-11-09 |
| CN101115759A (zh) | 2008-01-30 |
| CA2595766A1 (en) | 2006-08-17 |
| AU2006213061A1 (en) | 2006-08-17 |
| MX2007009590A (es) | 2007-09-12 |
| KR20070107030A (ko) | 2007-11-06 |
| AR052479A1 (es) | 2007-03-21 |
| US7442707B2 (en) | 2008-10-28 |
| TW200638932A (en) | 2006-11-16 |
| BRPI0607932A2 (pt) | 2016-11-08 |
| EP1856130A1 (en) | 2007-11-21 |
| CR9257A (es) | 2007-11-23 |
| IL184560A0 (en) | 2007-10-31 |
| PE20060996A1 (es) | 2006-11-13 |
| ZA200706628B (en) | 2010-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100377159B1 (ko) | 잔류 용매가 없는 클라리스로마이신의 결정형 2의 제조 방법 | |
| RU2007104518A (ru) | Полиморф рапамицина ii и его применение | |
| JP2005503386A5 (enExample) | ||
| WO2005095379B1 (en) | Crystalline methanesulfonic acid addition salts of imatinib | |
| JP2018520178A5 (enExample) | ||
| BR112019027457A2 (pt) | esteramina e sal da mesma, processo para preparação de esteramina ou sal da mesma, uso de esteramina e sal da mesma, e, composição de cuidados pessoais. | |
| CA2785998A1 (en) | Darunavir polymorph and process for preparation thereof | |
| JP2000507972A (ja) | 逆溶媒を使用する逆転写酵素阻害剤の結晶化方法 | |
| CN102639522A (zh) | 3-(4-氨基-1-氧代-1, 3-二氢-异吲哚-2-基)-哌啶-2, 6-二酮的固体形式及制备它们的方法 | |
| JP2008530090A5 (enExample) | ||
| RU2011148101A (ru) | Новые кристаллы сольватов | |
| CN111621014A (zh) | 基于羟脯氨酸的聚合物及其制备方法和解聚方法 | |
| CA2788709A1 (en) | Crystalline forms of l-malic acid salt of sunitinib | |
| CZ20014458A3 (cs) | Polymorfní formy krystalického (2-benzhydryl-l-azabicyklo[2,2,2]okt-3-yl)-(5-isopropyl-2-methoxybenzyl) amoniumchloridu jako antagonisté receptoru NK-1 | |
| JP2016108183A (ja) | セメント混和剤 | |
| TH81761A (th) | Cci-779 โพลีมอร์ฟ และ การใช้ของสารนั้น | |
| JPH08510477A (ja) | 新規なｎ−ベンゾイルメチル−ピペリジン類 | |
| EP4676492A2 (en) | High purity nitric oxide releasing compounds and methods of preparing same | |
| JP2007510715A (ja) | アトバコンの新規な多形およびその調製のプロセス | |
| WO2004083180A1 (en) | Novel crystalline forms of levetiracetam | |
| TW200829572A (en) | Crystal modifications | |
| WO2012038785A1 (en) | Polymorphs of rosuvastatin acetonide calcium ((3r,5s,6e)-7-[4-(4- fluorophenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimn)in-5- yl)vinyl)-2,2-dimethyl-l,3-dioxan-4-yl) acetic acid calcium salt | |
| KR20140006092A (ko) | 에피루비신 히드로클로라이드의 결정화 | |
| BG98439A (bg) | Кватернерни амониеви производни на (-) и (+) 10-(1-азобицикло /2.2.2/окт-3-ил-метил)-10н-фенотиазин,фармацевтични състави на тяхна основа и метод заполучаването им | |
| JP2007532538A (ja) | プロブコール誘導体の製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20091201 |